Literature DB >> 25335548

Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment.

E Zampieri1, M Bellani1, B Crespo-Facorro2, P Brambilla3.   

Abstract

Progressive enlargement of basal ganglia volume has been observed in schizophrenia individuals, potentially being sustained by chronic administration of antipsychotic drugs. Here we briefly summarise the state of the art of the role of antipsychotic in leading to increased basal ganglia in schizophrenia, particularly focusing on the caudate nucleus.

Entities:  

Year:  2014        PMID： 25335548      PMCID： PMC7192164          DOI： 10.1017/S204579601400064X

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN： 2045-7960            Impact factor:   6.892


  41 in total

1.  Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects.

Authors:  Handan Gunduz; Huwei Wu; Manzar Ashtari; Bernhard Bogerts; David Crandall; Delbert G Robinson; Jose Alvir; Jeffrey Lieberman; John Kane; Robert Bilder
Journal:  Biol Psychiatry       Date:  2002-05-15       Impact factor: 13.382

2.  Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study.

Authors:  Sitra Tauscher-Wisniewski; Johannes Tauscher; Jeff Logan; Bruce K Christensen; David J Mikulis; Robert B Zipursky
Journal:  Schizophr Res       Date:  2002-12-01       Impact factor: 4.939

3.  Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia.

Authors:  L Shihabuddin; M S Buchsbaum; E A Hazlett; J Silverman; A New; A M Brickman; V Mitropoulou; M Nunn; M B Fleischman; C Tang; L J Siever
Journal:  Arch Gen Psychiatry       Date:  2001-09

4.  No effect of obstetric complications on basal ganglia volumes in schizophrenia.

Authors:  Unn Kristin Haukvik; Thomas McNeil; Ragnar Nesvåg; Erik Söderman; Erik Jönsson; Ingrid Agartz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-03-01       Impact factor: 5.067

5.  Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study.

Authors:  Robin G McCreadie; Rangaswamy Thara; Ramachandran Padmavati; Tirupati N Srinivasan; Sandeep D Jaipurkar
Journal:  Arch Gen Psychiatry       Date:  2002-04

6.  Childhood-onset psychotic disorders: magnetic resonance imaging of volumetric differences in brain structure.

Authors:  S Kumra; J N Giedd; A C Vaituzis; L K Jacobsen; K McKenna; J Bedwell; S Hamburger; J E Nelson; M Lenane; J L Rapoport
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

7.  Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.

Authors:  Robert K McClure; Ingrid Phillips; Roukan Jazayerli; Allan Barnett; Richard Coppola; Daniel R Weinberger
Journal:  Psychiatry Res       Date:  2006-11-09       Impact factor: 3.222

8.  Caudate and putamen volumes in good and poor outcome patients with schizophrenia.

Authors:  Monte S Buchsbaum; Lina Shihabuddin; Adam M Brickman; Ruben Miozzo; Radovan Prikryl; Robert Shaw; Kenneth Davis
Journal:  Schizophr Res       Date:  2003-11-01       Impact factor: 4.939

9.  Brain structural changes in schizophrenia patients with persistent hallucinations.

Authors:  Owen G O'Daly; Sophia Frangou; Xavier Chitnis; Sukhwinder S Shergill
Journal:  Psychiatry Res       Date:  2007-08-27       Impact factor: 3.222

10.  Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression.

Authors:  Glenn Laywer; Håkan Nyman; Ingrid Agartz; Stefan Arnborg; Erik G Jönsson; Göran C Sedvall; Håkan Hall
Journal:  BMC Psychiatry       Date:  2006-08-10       Impact factor: 3.630
View more
  6 in total

1.  Subcortical Brain Volume Abnormalities in Individuals With an At-risk Mental State.

Authors:  Daiki Sasabayashi; Yoichiro Takayanagi; Tsutomu Takahashi; Naoyuki Katagiri; Atsushi Sakuma; Chika Obara; Masahiro Katsura; Naohiro Okada; Shinsuke Koike; Hidenori Yamasue; Mihoko Nakamura; Atsushi Furuichi; Mikio Kido; Yumiko Nishikawa; Kyo Noguchi; Kazunori Matsumoto; Masafumi Mizuno; Kiyoto Kasai; Michio Suzuki
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 2.  Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review.

Authors:  Roberto Roiz-Santiañez; Paula Suarez-Pinilla; Benedicto Crespo-Facorro
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

3.  Characteristics of Multimodal Brain Connectomics in Patients With Schizophrenia and the Unaffected First-Degree Relatives.

Authors:  Xiao Lin; WeiKai Li; Guangheng Dong; Qiandong Wang; Hongqiang Sun; Jie Shi; Yong Fan; Peng Li; Lin Lu
Journal:  Front Cell Dev Biol       Date:  2021-02-25

4.  Asphyxia at birth affects brain structure in patients on the schizophrenia-bipolar disorder spectrum and healthy participants.

Authors:  Laura Anne Wortinger; Kristine Engen; Claudia Barth; Ole A Andreassen; Kjetil Nordbø Jørgensen; Ingrid Agartz
Journal:  Psychol Med       Date:  2020-08-10       Impact factor: 10.592

5.  Abnormal functional connectivity of the striatum in first-episode drug-naive early-onset Schizophrenia.

Authors:  Yan Zhang; Yue Peng; Yichen Song; Youqi Zhou; Sen Zhang; Ge Yang; Yongfeng Yang; Wenqiang Li; Weihua Yue; Luxian Lv; Dai Zhang
Journal:  Brain Behav       Date:  2022-04-05       Impact factor: 3.405

6.  Altered Basal Ganglia Network Integration in Schizophrenia.

Authors:  Mingjun Duan; Xi Chen; Hui He; Yuchao Jiang; Sisi Jiang; Qiankun Xie; Yongxiu Lai; Cheng Luo; Dezhong Yao
Journal:  Front Hum Neurosci       Date:  2015-10-12       Impact factor: 3.169
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.